A Longitudinal Case Study of Recurrent Pyostomatitis-Pyodermatitis Vegetans Followed by the Subsequent Development of Bullous Pemphigoid With the Presence of Anti-BP230 Autoantibodies Six Years Later

一项关于复发性脓性口炎-增殖性脓皮病继发大疱性类天疱疮并伴有抗BP230自身抗体的纵向病例研究

阅读:1

Abstract

Pyostomatitis vegetans (PSV) is a rare inflammatory condition that has been strongly associated with inflammatory bowel disease (IBD). Additionally, certain cases of PSV have been reported to co-occur with pyodermatitis vegetans (PDV), resulting in a distinct mucocutaneous manifestation. Herein, we present a clinical case of PSV in a 64-year-old male patient diagnosed with ulcerative colitis (UC). The oral lesions demonstrated complete resolution following treatment with systemic glucocorticoids and immunosuppressants, in conjunction with targeted therapy for the underlying intestinal disease. During longitudinal follow-up, the patient subsequently developed PDV and, unexpectedly, exhibited recurrent bullous eruptions on cutaneous surfaces, specifically localized to the axillary and dorsal regions six years post-initial diagnosis. Enzyme-linked immunosorbent assay (ELISA) analysis revealed significantly elevated titers of circulating anti-BP230 antibodies in the serum samples. These clinical and immunologic findings, together with histopathological evaluation of the cutaneous lesions, established an additional diagnosis of bullous pemphigoid (BP). Both BP and PSV-PDV conditions remained clinically stable under treatment with topical and systemic glucocorticoids, with circulating anti-BP230 antibody titers normalizing eight months after the initiation of therapy. To the best of our knowledge, this represents the first documented case of a patient with PSV-PDV developing BP mediated by anti-BP230 antibodies during long-term follow-up observation. This finding underscores a potential novel disease association that warrants further exploration.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。